AI has the potential to significantly enhance diagnostic efficiency, allowing healthcare providers to quickly analyze medical images (e.g., X-Ray, MRI, CT, PET) and generate preliminary diagnostics for further review. This is achieved through a comprehensive workflow that involves: 1. Leveraging the deep expertise of medical professionals to accurately annotate medical images, creating a robust training dataset for the AI model. 2. Training computer vision models based on these datasets to achieve target performance levels. 3. Continuously refining these models over time through the incorporation of new data. Traditionally, this process demands a team of engineers to set up and maintain multiple tools, making it resource-intensive and costly. The technology offered here is a no-code, end-to-end platform that revolutionizes this process by enabling healthcare professionals to directly contribute their expertise through an AI-assisted image labeling tool. This tool allows technical teams to collaboratively and efficiently label large datasets with pixel-level accuracy. Model training and fine-tuning can then be managed by a single individual, significantly reducing the time from concept to deployment - from months to weeks - while also cutting costs associated with hiring specialized machine learning engineers. The technology owner has worked with universities, hospitals, and MedTech start-ups to develop unique computer vision solutions in the healthcare space. The technology owner is seeking collaborations with healthcare organizations aiming to harness computer vision to enhance operational efficiency and quality of care. Alongside the platform, professional services are available to support development, customize necessary integrations, and ensure the success of client projects.

This technology is a neurointerventional procedure, focusing on transradial access for acute ischemic and hemorrhagic stroke treatment. Traditionally, neurointerventions utilize transfemoral access, but this solution leverages the radial artery for access, providing a safer and more comfortable alternative. By reducing complications and shortening recovery times, the transradial approach significantly enhances patient experience.  The transradial access system comprises three components: a radial access sheath, a selective catheter, and a guiding catheter. Each component is designed to work in harmony, ensuring the system’s compatibility and optimal performance. The radial sheath maintains high structural integrity while reducing radial artery spasm and occlusion. The selective catheter offers multiple proprietary tip shapes for improved access to neuro arteries. The guiding catheter combines distal flexibility and proximal stiffness to ensure smooth catheter pushability and trackability, providing surgeons with an efficient and seamless experience. The trans-radial access catheters for neurosurgery are developed for Asian population whom have narrow arteries.  The technology owner is interested in joint R&D projects to co-develop the technology.

In the wake of the COVID-19 pandemic, people have developed new expectations for indoor air quality. It is no longer just about ventilation and purification, but also about providing clean and safe air for a healthier environment. Traditional UVC technology (254 nm) has been widely used in HVAC systems and air purifiers to disinfect airborne pathogens. To ensure its effectiveness, sufficient contact time is required, hence it is often used in unoccupied spaces due to safety concerns.  This solution utilises human-safe 222 nm far-UVC technology which has been shown to be able to effectively inactivate airborne pathogens while maintaining safety since it does not penetrate the outer layer of human skin or eyes. This allows for continuous disinfection of air in occupied spaces. By integrating 222 nm far-UVC technology into HVAC system, including air purification, air monitoring and IoT management platforms, the company offers a complete solution for clean and safe air. With integrated capabilities in both R&D and manufacturing, the company can provide tailor-made solutions for different industry applications. They are seeking collaborations with real estate developers, chain restaurant operators and pathogenic air sampling technology experts to further develop and commercialise this solution.

Immune cell activation and expansion for cell therapy is a strictly regulated process. It demands costly and labour-intensive optimization of cell culture conditions. Major limitations of these processes are cell quality and results consistency. Large amounts of expenses were spent on culture conditions, cell characterizations and quality control (QC) with differing culture protocols and recipes in growing CAR-T cells. This technology has established a biomaterial-based artificial cell platform to replace plastic beads, significantly improving cell stimulation performance. The artificial cells uses polysaccharides, lipids, and proteins to mimic live cells, meeting the demand for reproducibility and standardization while being 100% degradable. To address this gap, a modular, all-signals-in-one microbead-based platform has been developed for the next-generation cell therapy R&D and translation. In this delivery platform design, the modular feature allows rapid ‘plug-and-use’ of multiple surface and soluble signals to grow T-cells ex vivo without the need for extensive setup and integration of culture protocols. This platform aims to provide a seamless and straightforward cell culture experience for the industrial and academic research users to discover new types and applications of immune cell therapy. Additionally, the all-signals-in-one synthetic platform mimics the natural antigen presenting cells to activate and expand T-cells on dish, allowing cell manufacturers to ‘mix-and-grow’ immune cells with reduced effort or technical expertise. This aims to improve the cost-effectiveness and scalability of cell therapy manufacturing. The technology provider is seeking collaborations with cell therapy CDMOs/CMOs in licensing and various R&D developments.

This technology focuses on the production of high-quality graphene oxide (GO) and reduced graphene oxide (rGO), designed for various industrial applications. Graphene oxide demonstrates superior electrical, thermal, and mechanical properties, making it an ideal candidate for industries such as electronics, energy storage, coatings, and composites. By reducing GO to rGO, its conductive properties can be enhanced. With the rising demand for advanced nanomaterials that enhance performance while supporting sustainable manufacturing practices, this technology ensures consistent quality and cost-effectiveness of GO and rGO for commercial use. The technology owner is seeking for joint R&D collaborations with industrial manufacturers and companies focused on sustainable materials innovation. Target partners include those in electronics, energy, and materials science sectors, interested in integrating graphene oxide into their new product development pipeline.

Fungal-like Adhesive Materials (FLAM) represent an innovative family of materials inspired by the cell walls of fungus-like oomycetes. FLAMs are engineered by organizing the two most abundant and widely available natural molecules in their native configuration, resulting in a material that is lightweight, durable, and highly cost-effective. This groundbreaking composite is fully biodegradable, eliminating the need for organic solvents or synthetic materials, making it an eco-friendly alternative. FLAM can be locally produced as part of natural ecological cycles, contributing to sustainable manufacturing and ensuring long-term resource security for industries. In addition to its sustainability benefits, FLAM’s versatility allows it to be easily molded or processed with traditional manufacturing techniques, opening the door to a wide range of applications across various industries. This technology has been locally produced in Singapore as a by-product of waste management. The technology owner is looking for collaboration in test-bedding. FLAM can replace the use of plastic and wood in many applications. 

The leather industry, long dependent on livestock farming, is facing growing criticism for its significant environmental impact. Leather production contributes to deforestation, high water consumption, and the release of methane—a potent greenhouse gas—from livestock farming. Additionally, the tanning and dyeing processes generate hazardous waste and chemicals, leading to air and water pollution. While synthetic leather offers an animal-free alternative, it relies heavily on petroleum-based plastics like polyurethane (PU) and polyvinyl chloride (PVC), which contribute to microplastic pollution and rely on finite fossil fuel resources. Meanwhile, large quantities of agricultural waste, such as cocoa shells, mangosteen peels, and durian fibers, often end up in landfills, where they release methane as they decompose, further exacerbating environmental concerns. This technology transforms agricultural waste into a sustainable, plant-based leather alternative that addresses both environmental sustainability and the rising demand for animal-free products. By utilizing discarded cocoa shells, along with mangosteen peels and durian fibers, it offers several benefits. The natural fibers from durian provide antibacterial properties, making it ideal for products like shoes, bags, and jackets prone to bacterial buildup. Additionally, the production process emits fewer greenhouse gases, consumes less water, and repurposes agricultural waste, aligning with circular economy principles. This eco-friendly material is biodegradable and designed for recycling, offering a more sustainable alternative to traditional and synthetic leathers. The technology owner is looking for collaborations with textile/furniture companies that focuses on sustainability. 

Superoxide dismutase (SOD) is a key antioxidant enzyme that protects cells from oxidative stress by catalysing the conversion of superoxide radicals into less harmful molecules like oxygen and hydrogen peroxide. These radicals are produced during normal cellular metabolism but can cause significant damage to DNA, proteins, and lipids if not neutralised. SOD helps maintain cellular integrity by reducing this damage, supporting overall health and longevity. Given its role in protecting cell damage, SOD has been utilised in skincare products, cosmeceuticals, dietary supplements, medical and therapeutic products as well as functional foods. Current methods to produce SOD include natural extraction from plants, microbial fermentation and recombinant DNA technology. However, challenges such as low yield, variation in quality and concentration, high costs and regulatory issues still remain. The technology owner uses specific strains of microorganism and advanced biotechnology processes to produce SOD at high yields via fermentation in a sustainable and efficient manner. The enzyme is then extracted and concentrated during downstream processing. This technology could ensure a consistent and scalable supply of SOD for commercial use. The company is seeking collaborations with skincare brands and cosmetic manufacturers interested in co-developing or licensing the technology for mass-market production and distribution.

Satay has been a beloved comfort food for generations of Singaporeans. To meet the ever-growing demand and ensure consistent supply, one satay business is automating its production. By embracing automation, the goal is to streamline processes, increase efficiency, and continue delivering the same high-quality satay that customers know and love. The satay company is seeking to work with automation companies to design an equipment portion and line the meats for skewering.

Supported by the government’s "30 by 30" initiative, Singapore aims to produce 30% of its nutritional needs by 2030, emphasising sustainability in its food production practices. A local fish farm believes in eating well and respecting the environment, where fish are given space to swim in the ocean with tides and currents. These fishes are farmed without any growth enhancements. More than 70% of the farm is made of reused materials and we use renewable solar energy for power. Milkfish is a hardy fish to farm. However, with over 200 tiny bones, it has not gain popularity with consumers. Manual removal of these bones are labour intensive. Therefore, the local fish farm would like to work with automation companies to customise an equipment to automate the deboning process of milkfish.